Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Merck Vaccine Unit Tops $1 Billion In Second Quarter Sales On Strength Of New Products

Jul 23 2007

• By Jessica Merrill

Related Content

Merck’s Novel HIV Drug Isentress Granted Six-Month FDA Review

Jun 27 2007

FDA: For Niaspan Reduced Flushing Claim, Pre-Defined Criteria Necessary

Apr 13 2007

Merck’s Biotech Pipeline Gets A Boost From Two Acquisitions

May 09 2006

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window